歐化(01711.HK)2024/2025年度總收入減少至1.53億港元
格隆匯6月25日丨歐化(01711.HK)公告,2024/2025年度全年業績,在市場環境充滿挑戰及消費氣氛低迷的背景下,於年度集團的總收入不可避免地減少至1.53億港元(2024年:1.7億港元)。集團於年度錄得淨虧損4100萬港元(2024年:2500萬港元)。每股基本虧損爲5.13港仙(2024年:3.13港仙)。
地緣政治緊張以及通脹及失業率等多項經濟不確定性抑制了消費氣氛。儘管年度減息及取消所有樓市降溫措施,但本地住宅物業價格的下跌趨勢並無減弱跡象。產品種類及價格區間的市場競爭日益加劇。面對市場挑戰以及低迷的物業市場,年度家俬市場的經營環境仍較爲複雜。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.